For rheumatologists, the findings suggest that digital mental health tools may serve as accessible, scalable adjuncts to traditional care, addressing the unmet psychological needs often seen in this patient population.
For rheumatologists, the findings suggest that digital mental health tools may serve as accessible, scalable adjuncts to traditional care, addressing the unmet psychological needs often seen in this patient population.
Recognizing whether an IMID predates or follows cancer diagnosis may guide clinical decisions regarding immunosuppression, surveillance, and therapy sequencing.
Recognizing whether an IMID predates or follows cancer diagnosis may guide clinical decisions regarding immunosuppression, surveillance, and therapy sequencing.
A prospective cohort study finds that poor sleep consistently predicts greater pain-related interference with daily life 6 months later in patients with early RA, suggesting sleep as a potential target for improving long-term pain outcomes.
A prospective cohort study finds that poor sleep consistently predicts greater pain-related interference with daily life 6 months later in patients with early RA, suggesting sleep as a potential target for improving long-term pain outcomes.
A multidisciplinary lifestyle program combining a whole-food, plant-based diet, exercise, and stress management led to lasting reductions in symptoms of RA and osteoarthritis, with improvements maintained 2 years after the intervention.
A multidisciplinary lifestyle program combining a whole-food, plant-based diet, exercise, and stress management led to lasting reductions in symptoms of RA and osteoarthritis, with improvements maintained 2 years after the intervention.
A propensity score–matched cohort study reveals that febuxostat use carries a significantly higher risk of liver enzyme abnormalities than benzbromarone, particularly among patients with pre-existing liver function elevations.
A propensity score–matched cohort study reveals that febuxostat use carries a significantly higher risk of liver enzyme abnormalities than benzbromarone, particularly among patients with pre-existing liver function elevations.
A post hoc analysis of a randomized clinical trial finds no consistent link between plasma colchicine concentrations and flare prevention or adverse effects—challenging the utility of therapeutic drug monitoring in routine gout care.
A post hoc analysis of a randomized clinical trial finds no consistent link between plasma colchicine concentrations and flare prevention or adverse effects—challenging the utility of therapeutic drug monitoring in routine gout care.
New research identifies social and clinical factors—such as marital status, age, and colchicine use—that may influence whether patients seek outpatient care after visiting the emergency department for a gout flare.
New research identifies social and clinical factors—such as marital status, age, and colchicine use—that may influence whether patients seek outpatient care after visiting the emergency department for a gout flare.
Structured monitoring and patient-physician collaboration are critical to successful tapering of anti-tumor necrosis factor therapy for patients with psoriatic arthritis or axial spondyloarthritis.
Structured monitoring and patient-physician collaboration are critical to successful tapering of anti-tumor necrosis factor therapy for patients with psoriatic arthritis or axial spondyloarthritis.
In 2 large cohorts with up to 20 years of follow-up, baseline chondrocalcinosis significantly increased the odds of developing radiographic knee osteoarthritis—but not knee pain.
In 2 large cohorts with up to 20 years of follow-up, baseline chondrocalcinosis significantly increased the odds of developing radiographic knee osteoarthritis—but not knee pain.
A post-hoc analysis of a 72-week randomized trial shows that targeted urate-lowering therapy improves physical function, mobility, and pain in gout patients, with measurable benefits beginning as early as 24 weeks.
A post-hoc analysis of a 72-week randomized trial shows that targeted urate-lowering therapy improves physical function, mobility, and pain in gout patients, with measurable benefits beginning as early as 24 weeks.
Dr England recaps his presentation on interstitial lung disease among patients with rheumatoid arthritis, including the importance of early detection and how to diagnose this condition,
Dr England recaps his presentation on interstitial lung disease among patients with rheumatoid arthritis, including the importance of early detection and how to diagnose this condition,
Professor Iain McInnes of the University of Glasgow delves into the latest science on the importance of the interleukin-12 interleukin-17 axis in axial spondyloarthritis.
Professor Iain McInnes of the University of Glasgow delves into the latest science on the importance of the interleukin-12 interleukin-17 axis in axial spondyloarthritis.
In part 1 of this video series, Professor Iain McInnes of the University of Glasgow discusses how advances in molecular medicine have revolutionized the treatment of axial spondyloarthritis.
In part 1 of this video series, Professor Iain McInnes of the University of Glasgow discusses how advances in molecular medicine have revolutionized the treatment of axial spondyloarthritis.
Dr Alfred Kim from Barnes Jewish Hospital and Washington University School of Medicine reviews the latest breakthroughs and coming advances in therapeutics for systemic lupus erythematosus.
Dr Alfred Kim from Barnes Jewish Hospital and Washington University School of Medicine reviews the latest breakthroughs and coming advances in therapeutics for systemic lupus erythematosus.
Dr Haberman characterized a cohort of patients with psoriatic arthritis to evaluate how race, ethnicity, and sex may inform features of clinical presentation, comorbidities, disease course and outcomes.
Dr Haberman characterized a cohort of patients with psoriatic arthritis to evaluate how race, ethnicity, and sex may inform features of clinical presentation, comorbidities, disease course and outcomes.
Dr Michaud related his personal experience as a patient diagnosed with juvenile rheumatoid arthritis at the age of 3, providing perspective as both a patient and a rheumatology research scientists at ACR Convergence.
Dr Michaud related his personal experience as a patient diagnosed with juvenile rheumatoid arthritis at the age of 3, providing perspective as both a patient and a rheumatology research scientists at ACR Convergence.
Dr Eder recaps her presentation from ACR Convergence 2023 on research relating high-sensitivity C reactive protein and the risk of developing psoriatic arthritis among patients with psoriasis.
Dr Eder recaps her presentation from ACR Convergence 2023 on research relating high-sensitivity C reactive protein and the risk of developing psoriatic arthritis among patients with psoriasis.
Structured monitoring and patient-physician collaboration are critical to successful tapering of anti-tumor necrosis factor therapy for patients with psoriatic arthritis or axial spondyloarthritis.
Structured monitoring and patient-physician collaboration are critical to successful tapering of anti-tumor necrosis factor therapy for patients with psoriatic arthritis or axial spondyloarthritis.
Gout remission rates steadily increase to 63% by year 6 on urate-lowering therapy, with odds of remission affected by age, race, comorbidities, disease severity, and choice of treatment.
Gout remission rates steadily increase to 63% by year 6 on urate-lowering therapy, with odds of remission affected by age, race, comorbidities, disease severity, and choice of treatment.
Findings of recent study underscore the need for age-aware training and the adoption of frameworks like the Geriatric 5Ms to mitigate age-related disparities in rheumatologic care.
Findings of recent study underscore the need for age-aware training and the adoption of frameworks like the Geriatric 5Ms to mitigate age-related disparities in rheumatologic care.
Female patients were significantly older and had higher pain scores, while men had higher CRP levels, suggesting potential disparities in disease presentation and inflammation markers.
Female patients were significantly older and had higher pain scores, while men had higher CRP levels, suggesting potential disparities in disease presentation and inflammation markers.
Integrating brief questionnaires like IBIS-Q into clinic workflows may facilitate earlier SpA recognition, improve interdisciplinary care coordination, and ultimately enhance long-term outcomes for patients with IBD.
Integrating brief questionnaires like IBIS-Q into clinic workflows may facilitate earlier SpA recognition, improve interdisciplinary care coordination, and ultimately enhance long-term outcomes for patients with IBD.
These real-world findings may be of interest to clinicians managing older adults with symptomatic, advanced knee OA who are not candidates for or are delaying surgery.
These real-world findings may be of interest to clinicians managing older adults with symptomatic, advanced knee OA who are not candidates for or are delaying surgery.
The results offer practicing rheumatologists a potential new direction for pain management in knee osteoarthritis among patients with metabolic comorbidities.
The results offer practicing rheumatologists a potential new direction for pain management in knee osteoarthritis among patients with metabolic comorbidities.
These findings offer clarification amid previously conflicting data on HCQ’s renal benefits in LN and underscore the importance of long-term HCQ adherence.
These findings offer clarification amid previously conflicting data on HCQ’s renal benefits in LN and underscore the importance of long-term HCQ adherence.
Dacre Knight, MD, from Mayo Clinic-Florida, provides insights into hypermobility disorders, including Ehlers-Danlos Syndrome, and why they are difficult to diagnose and challenging to treat.
Dacre Knight, MD, from Mayo Clinic-Florida, provides insights into hypermobility disorders, including Ehlers-Danlos Syndrome, and why they are difficult to diagnose and challenging to treat.
Dr Calabrese discusses the similarities between long COVID, fibromyalgia, and in its most severe form, myalgic encephalomyelitis/chronic fatigue syndrome, and the importance of reassuring patients that their symptoms and conditions are real.
Dr Calabrese discusses the similarities between long COVID, fibromyalgia, and in its most severe form, myalgic encephalomyelitis/chronic fatigue syndrome, and the importance of reassuring patients that their symptoms and conditions are real.
Dr Paudel reviews research she and colleagues conducted to validate the EULAR definition of difficult-to-treat rheumatoid arthritis, and differences among patients with difficult-to-treat RA versus those with controlled disease.
Dr Paudel reviews research she and colleagues conducted to validate the EULAR definition of difficult-to-treat rheumatoid arthritis, and differences among patients with difficult-to-treat RA versus those with controlled disease.
Drs Majithia and Butendieck provide some perspective on the continuing issues surrounding the diagnosis and effective treatment of gout, the most common inflammatory arthritis in the US.
Drs Majithia and Butendieck provide some perspective on the continuing issues surrounding the diagnosis and effective treatment of gout, the most common inflammatory arthritis in the US.
In this podcast, Drs England and Smith discuss the key recommendations and how to implement exercise, rehabilitation, diet, and additional interventions as part of an integrative management approach for people with rheumatoid arthritis.
In this podcast, Drs England and Smith discuss the key recommendations and how to implement exercise, rehabilitation, diet, and additional interventions as part of an integrative management approach for people with rheumatoid arthritis.
In a cross-sectional study of 36 isolated nail psoriasis patients, 7 of them (19%) went on to develop psoriatic arthritis in the following years. Is there more to this connection between isolated nail psoriasis and early detection of PsA? Dr...
In a cross-sectional study of 36 isolated nail psoriasis patients, 7 of them (19%) went on to develop psoriatic arthritis in the following years. Is there more to this connection between isolated nail psoriasis and early detection of PsA? Dr...
Dr Jeffrey Sparks and research assistant Emily Kowalski from Brigham & Women's Hospital in Boston share their findings from a study of the risk factors found among patient with systemic rheumatic diseases for repeat infections with COVID-19.
Dr Jeffrey Sparks and research assistant Emily Kowalski from Brigham & Women's Hospital in Boston share their findings from a study of the risk factors found among patient with systemic rheumatic diseases for repeat infections with COVID-19.
Dr Birnbaum comments on how the new rule from the Centers for Medicare & Medicaid Services setting tighter timelines for health insurers to act on requests for authorization for medications and procedures.
Dr Birnbaum comments on how the new rule from the Centers for Medicare & Medicaid Services setting tighter timelines for health insurers to act on requests for authorization for medications and procedures.
Dr Leonard Calabrese of the Cleveland Clinic discusses the similarities and differences of fibromyalgia, chronic fatigue syndrome, and long COVID, and why classifying these diseases properly is important to diagnosis and treatment.
Dr Leonard Calabrese of the Cleveland Clinic discusses the similarities and differences of fibromyalgia, chronic fatigue syndrome, and long COVID, and why classifying these diseases properly is important to diagnosis and treatment.
In this special podcast Dr Rita Knotts, with the Center for Esophageal Health at NYU-Langone, and Dr Elizabeth Volkmann, founder and codirector of the UCLA Connective Tissue Disease-Related Interstitial Lung Disease, discuss the intersection...
In this special podcast Dr Rita Knotts, with the Center for Esophageal Health at NYU-Langone, and Dr Elizabeth Volkmann, founder and codirector of the UCLA Connective Tissue Disease-Related Interstitial Lung Disease, discuss the intersection...
Earlier identification of patients at risk of developing difficult-to-treat rheumatoid arthritis would allow treatment to begin sooner and optimize outcomes, researchers say.
Earlier identification of patients at risk of developing difficult-to-treat rheumatoid arthritis would allow treatment to begin sooner and optimize outcomes, researchers say.
In a cohort of patients with established rheumatoid arthritis being treated with first-line biologic or targeted synthetic DMARDs, 17% developed difficult-to-treat rheumatoid arthritis over 5 years.
In a cohort of patients with established rheumatoid arthritis being treated with first-line biologic or targeted synthetic DMARDs, 17% developed difficult-to-treat rheumatoid arthritis over 5 years.
Subgroup analyses revealed that Africa had the highest prevalence of RA-ILD, while Europe had the lowest; socioeconomic status was inversely correlated with RA-ILD prevalence.
Subgroup analyses revealed that Africa had the highest prevalence of RA-ILD, while Europe had the lowest; socioeconomic status was inversely correlated with RA-ILD prevalence.
Although residual fatigue is prevalent among patients with rheumatoid arthritis in remission, inflammatory activity appears to have a stronger association with severe fatigue.
Although residual fatigue is prevalent among patients with rheumatoid arthritis in remission, inflammatory activity appears to have a stronger association with severe fatigue.
Which therapies work fastest to reduce pain and improve function in rheumatoid arthritis? Research presented at ACR Convergence provides some guidance.
Which therapies work fastest to reduce pain and improve function in rheumatoid arthritis? Research presented at ACR Convergence provides some guidance.
Among patients with psoriatic arthritis who achieved minimal disease activity, 40% still reported pain above the acceptable threshold after 6 months of treatment, researchers reported at ACR Convergence.
Among patients with psoriatic arthritis who achieved minimal disease activity, 40% still reported pain above the acceptable threshold after 6 months of treatment, researchers reported at ACR Convergence.
Patients with psoriatic arthritis and axial spondyloarthritis may be able to safely taper tumor necrosis factor inhibitors using a treat-to-target approach, new research indicates.
Patients with psoriatic arthritis and axial spondyloarthritis may be able to safely taper tumor necrosis factor inhibitors using a treat-to-target approach, new research indicates.
Investigators examined the association between multimorbidity in rheumatoid arthritis and its association with flares and remission in comparison to seropositivity.
Investigators examined the association between multimorbidity in rheumatoid arthritis and its association with flares and remission in comparison to seropositivity.
A retrospective cohort study found that patients with rheumatoid arthritis treated with Janus kinase inhibitors were no less adherent to their medication regimen after the addition of a black box warning by the US Food and Drug Administration
A retrospective cohort study found that patients with rheumatoid arthritis treated with Janus kinase inhibitors were no less adherent to their medication regimen after the addition of a black box warning by the US Food and Drug Administration
The biosimilar was also approved to treat moderately to severely active Crohn’s disease and ulcerative colitis, and moderate to severe plaque psoriasis.
The biosimilar was also approved to treat moderately to severely active Crohn’s disease and ulcerative colitis, and moderate to severe plaque psoriasis.
Bone loss has been found to play a significant role in axial spondyloarthritis (axSpA) and regular assessments are recommended. How do you assess bone loss in your patients with axSpA?DXA scanTrabecular bone score Quantitative computed...
Bone loss has been found to play a significant role in axial spondyloarthritis (axSpA) and regular assessments are recommended. How do you assess bone loss in your patients with axSpA?DXA scanTrabecular bone score Quantitative computed...
Is there any association between nonsteroidal anti-inflammatory drugs (NSAIDs), axial spondyloarthritis (axSpA), and risk of cardiovascular disease (CVD)?a) No, there is no evidence that NSAID use increases the risk of CVD on patients with...
Is there any association between nonsteroidal anti-inflammatory drugs (NSAIDs), axial spondyloarthritis (axSpA), and risk of cardiovascular disease (CVD)?a) No, there is no evidence that NSAID use increases the risk of CVD on patients with...
Is obesity a risk and severity factor among patients with rheumatic conditions? Or does weight have no bearing on autoimmune disorders? Find out with one quick question!
Is obesity a risk and severity factor among patients with rheumatic conditions? Or does weight have no bearing on autoimmune disorders? Find out with one quick question!
Researchers developed the Psoriatic Arthritis Risk Estimation Tool (PRESTO) to predict the 1- and 5-year risk of developing psoriatic arthritis in patients with psoriasis. Take our quiz to test your knowledge on the subject!
Researchers developed the Psoriatic Arthritis Risk Estimation Tool (PRESTO) to predict the 1- and 5-year risk of developing psoriatic arthritis in patients with psoriasis. Take our quiz to test your knowledge on the subject!
More than 50% of patients with rheumatoid arthritis (RA) suffer from sleep fragmentation and obstructive sleep apnea, which effectively results in poor quality of sleep. Dr Patricia Katz explains.
More than 50% of patients with rheumatoid arthritis (RA) suffer from sleep fragmentation and obstructive sleep apnea, which effectively results in poor quality of sleep. Dr Patricia Katz explains.
Can digital health tools offer more insight outside of clinical setting in the treatment of rheumatoid arthritis? Dr Shilpa Venkatachalam spoke on the topic at ACR Convergence.
Can digital health tools offer more insight outside of clinical setting in the treatment of rheumatoid arthritis? Dr Shilpa Venkatachalam spoke on the topic at ACR Convergence.
Understand the efficacy and safety of RINVOQ, a once-daily oral JAK inhibitor, for the treatment of active psoriatic arthritis (PsA) in adult TNFi-IR patients.
Understand the efficacy and safety of RINVOQ, a once-daily oral JAK inhibitor, for the treatment of active psoriatic arthritis (PsA) in adult TNFi-IR patients.
Metabolic dysfunction-associated steatotic liver disease was consistently associated with osteoarthritis across a variety of subgroups, researchers found.
Metabolic dysfunction-associated steatotic liver disease was consistently associated with osteoarthritis across a variety of subgroups, researchers found.